Endocrine dysfunction in impotence: incidence, significance and cost-effective screening.

Endocrine dysfunction in impotence: incidence, significance and cost-effective screening.

Item
http://www.wikidata.org/entity/Q48652144
Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and functionThe role of routine serum testosterone testing: routine hormone analysis is not indicated as an initial screening test in the evaluation of erectile dysfunctionHypogonadism and erectile dysfunction: the role for testosterone therapy.Erectile dysfunction: management update.Does regular consumption of green tea influence expression of vascular endothelial growth factor and its receptor in aged rat erectile tissue? Possible implications for vasculogenic erectile dysfunction progression.Epidemiology of male sexual dysfunction.Evaluation of impotence."Organic" erection dysfunction: diagnosis and treatment.Is there any relation between serum levels of total testosterone and the severity of erectile dysfunction?The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction.Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone.
P2860

Endocrine dysfunction in impotence: incidence, significance and cost-effective screening.

Item
http://www.wikidata.org/entity/Q48652144
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh-hant
name
Endocrine dysfunction in impotence: incidence, significance and cost-effective screening.
@en
Endocrine dysfunction in impotence: incidence, significance and cost-effective screening.
@nl
type
label
Endocrine dysfunction in impotence: incidence, significance and cost-effective screening.
@en
Endocrine dysfunction in impotence: incidence, significance and cost-effective screening.
@nl
prefLabel
Endocrine dysfunction in impotence: incidence, significance and cost-effective screening.
@en
Endocrine dysfunction in impotence: incidence, significance and cost-effective screening.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Endocrine dysfunction in impotence: incidence, significance and cost-effective screening.
@en
P2093
P304
P31
P356
10.1016/S0022-5347(17)49454-7
P407
P433
P478
P577
P698